Immunocompromised patients with protracted COVID-19: a review of “long persisters”
Abstract Purpose of Review Certain immunocompromised individuals are at risk for
protracted COVID-19, in which SARS-CoV-2 leads to a chronic viral infection. However, the …
protracted COVID-19, in which SARS-CoV-2 leads to a chronic viral infection. However, the …
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
T Brosh-Nissimov, N Ma'aravi, D Leshin-Carmel… - Journal of Microbiology …, 2024 - Elsevier
We present a retrospective study on the treatment outcomes of severely
immunocompromised patients with persistent COVID-19. The study analyzed data from 14 …
immunocompromised patients with persistent COVID-19. The study analyzed data from 14 …
[HTML][HTML] Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
D Totschnig, D Doberer, R Haberl, C Wenisch… - IDCases, 2022 - Elsevier
Background Patients having undergone B-cell-depletion with anti-CD20-antibodies have a
higher risk of mortality, delayed viral clearance and prolonged infection due to severe acute …
higher risk of mortality, delayed viral clearance and prolonged infection due to severe acute …
Persistent SARS-CoV-2 infection in a patient with nephrotic syndrome under rituximab therapy: Successful treatment with a combination of remdesivir and monoclonal …
A Shimizu, I Shirai, K Ogawa, A Miura, K Haruhara… - Internal …, 2022 - jstage.jst.go.jp
Rituximab is an effective treatment for frequently relapsing/steroid-dependent nephrotic
syndrome, but there is concern about infections caused by humoral immunodeficiency. We …
syndrome, but there is concern about infections caused by humoral immunodeficiency. We …
[HTML][HTML] A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma
T Yanagihara, M Kadowaki, J Otsuka, A Ishimatsu… - Cureus, 2023 - ncbi.nlm.nih.gov
We report a case of a female patient in her 50s, previously diagnosed with follicular
lymphoma (now in complete remission), who was admitted to our hospital due to antibiotic …
lymphoma (now in complete remission), who was admitted to our hospital due to antibiotic …
A fatal breakthrough COVID-19 case following bendamustine-rituximab therapy
K Kamegai, N Iwamoto, T Togano, K Maeda… - International Journal of …, 2022 - Elsevier
Although messenger ribonucleic acid vaccines are substantially effective toward SARS-CoV-
2 infection, patients with hematologic malignancies are still prone to the virus. Herein, we …
2 infection, patients with hematologic malignancies are still prone to the virus. Herein, we …